SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-004375
Filing Date
2017-01-26
Accepted
2017-01-26 21:35:42
Documents
2
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5161
2 EX-24.1 ex-24d1.htm EX-24.1 9343
  Complete submission text file 0001104659-17-004375.txt   15867
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O JOUNCE THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE CAMBRIDGE MA 02138
Business Address
Trehu Elizabeth (Reporting) CIK: 0001693456 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 17551461